Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 2
2(40.0%)
5Total
N/A(3)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT01512329Phase 2Completed

Pacing Activity Self-management for Patients With Multiple Sclerosis

Role: collaborator

NCT01512342Phase 2Completed

Pacing Activity Self-management for Patients With Chronic Fatigue Syndrome

Role: collaborator

NCT01671540Not ApplicableUnknown

Effects of IPV Assessed With Functional Imaging

Role: collaborator

NCT01356654Not ApplicableUnknown

Transcranial Direct Current Stimulation in Stroke Rehabilitation

Role: collaborator

NCT01154647Not ApplicableUnknown

Pain Inhibition in Patients With Rheumatoid Arthritis and Central Sensitivity Syndromes

Role: collaborator

All 5 trials loaded